Today's Daily Dose brings you news about approval of Amicus Fabry disease drug in Japan; commercial launch of La Jolla's GIAPREZA in the U.S.; Emergent Bio's stock repurchase program; better-than expected quarterly financial results of HTG Molecular Diagnostics; FDA postponing the decision date on Progenics' AZEDRA, and reverse stock split of Ritter.
from RTT - Biotech http://ift.tt/2HZDMIR
via IFTTT
No comments:
Post a Comment